Acquisitions in Region of Southern Denmark, Denmark
Showing 3 transactions.
-
CERTANIA Acquires Mediator ApSJune 26, 2024
- Buyer
- CERTANIA, GREENPEAK Partners
- Target
- Mediator ApS
- Industry
- Professional Services
- Location
- Region of Southern Denmark, Denmark
- Type
- Addon
Munich-based CERTANIA, a testing, inspection and certification group backed by GREENPEAK Partners, has added Mediator ApS, a Kolding, Denmark regulatory advisory specialist for chemical and hazardous-substance compliance, to its group. The deal brings Mediator's regulatory expertise (including subscription legislative services) into CERTANIA's regulatory, sustainability, food & environment segment as an add-on to accelerate international growth.
-
Kirk Kapital-led Consortium Acquires Mobilhouse from Adelis Equity PartnersNovember 24, 2022
- Buyer
- Kirk Kapital (consortium lead)
- Target
- Mobilhouse
- Seller
- Adelis Equity Partners Fund II
- Industry
- Building Products
- Location
- Region of Southern Denmark, Denmark
- Type
- Divestiture
A consortium led by Danish investment company Kirk Kapital has acquired Mobilhouse, a Fredericia-headquartered provider of temporary modular buildings, from Adelis Equity Partners Fund II. Adelis, which acquired Mobilhouse in 2019 and helped transition the business to a 100% rental model, has divested its majority stake; financial terms were not disclosed.
-
Philip Morris International Acquires Fertin Pharma from EQT Private EquityJuly 1, 2021
- Buyer
- Philip Morris International
- Target
- Fertin Pharma
- Seller
- EQT Private Equity, Bagger-Sørensen & Co. (Bagger-Sørensen family)
- Industry
- Pharmaceuticals
- Location
- Region of Southern Denmark, Denmark
- Type
- Buyout
Philip Morris International has agreed to acquire Fertin Pharma, a Denmark-headquartered specialist CDMO in oral and intra-oral delivery technologies, from EQT Private Equity for a headline enterprise value of DKK 5.1 billion. Fertin Pharma — which operates sites in Denmark, Canada and India and employs more than 860 people — will strengthen PMI's smoke-free and beyond-nicotine product capabilities; the transaction is subject to customary approvals.